1. Home
  2. MYNZ vs HUGE Comparison

MYNZ vs HUGE Comparison

Compare MYNZ & HUGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • HUGE
  • Stock Information
  • Founded
  • MYNZ 2021
  • HUGE 1998
  • Country
  • MYNZ Germany
  • HUGE Canada
  • Employees
  • MYNZ N/A
  • HUGE N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • HUGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYNZ Health Care
  • HUGE Health Care
  • Exchange
  • MYNZ Nasdaq
  • HUGE Nasdaq
  • Market Cap
  • MYNZ 9.8M
  • HUGE 7.8M
  • IPO Year
  • MYNZ 2021
  • HUGE N/A
  • Fundamental
  • Price
  • MYNZ $0.36
  • HUGE $0.14
  • Analyst Decision
  • MYNZ Buy
  • HUGE
  • Analyst Count
  • MYNZ 2
  • HUGE 0
  • Target Price
  • MYNZ $3.00
  • HUGE N/A
  • AVG Volume (30 Days)
  • MYNZ 1.4M
  • HUGE 2.6M
  • Earning Date
  • MYNZ 08-13-2024
  • HUGE 09-12-2024
  • Dividend Yield
  • MYNZ N/A
  • HUGE N/A
  • EPS Growth
  • MYNZ N/A
  • HUGE N/A
  • EPS
  • MYNZ N/A
  • HUGE N/A
  • Revenue
  • MYNZ $895,479.00
  • HUGE N/A
  • Revenue This Year
  • MYNZ $67.40
  • HUGE N/A
  • Revenue Next Year
  • MYNZ $191.13
  • HUGE N/A
  • P/E Ratio
  • MYNZ N/A
  • HUGE N/A
  • Revenue Growth
  • MYNZ 69.00
  • HUGE N/A
  • 52 Week Low
  • MYNZ $0.32
  • HUGE $0.13
  • 52 Week High
  • MYNZ $4.71
  • HUGE $1.68
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 39.72
  • HUGE 35.95
  • Support Level
  • MYNZ $0.34
  • HUGE $0.14
  • Resistance Level
  • MYNZ $0.46
  • HUGE $0.16
  • Average True Range (ATR)
  • MYNZ 0.07
  • HUGE 0.01
  • MACD
  • MYNZ 0.00
  • HUGE 0.01
  • Stochastic Oscillator
  • MYNZ 9.09
  • HUGE 33.57

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

About HUGE FSD Pharma Inc. Class B Subordinate Voting Shares

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Share on Social Networks: